Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

New recommendations for pneumococcal vaccination in patients with autoimmune and inflammatory diseases.

Hernández-Flórez D, González-Benítez R, Valor L.

Med Clin (Barc). 2016 Dec 5. pii: S0025-7753(16)30516-4. doi: 10.1016/j.medcli.2016.10.007. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
27931862
2.

Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity.

Hernández-Flórez D, Valor L.

Reumatol Clin. 2016 Nov - Dec;12(6):303-306. doi: 10.1016/j.reuma.2016.07.011. English, Spanish. No abstract available.

3.

The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?

Morales-Lozano R, Martínez-Barrio J, González-Fernández ML, López-Longo FJ, Ovalles-Bonilla JG, Valor L, Janta I, Nieto JC, Hernández-Flórez D, González CM, Monteagudo I, Garrido J, Carreño L, Naredo E.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):609-17.

4.

Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?

Valor L, Martínez-Estupiñán L, Janta I, Nieto JC, Ovalles-Bonilla JG, González-Fernández C, Del Rio T, Hernández-Flórez D, Monteagudo I, López-Longo FJ, Naredo E.

Rheumatol Int. 2016 Jun;36(6):793-7. doi: 10.1007/s00296-016-3477-4.

PMID:
27072348
5.

To what extent is foot pain related to biomechanical changes and ultrasound-detected abnormalities in rheumatoid arthritis?

González-Fernández ML, Valor L, Morales-Lozano R, Hernández-Flórez D, López-Longo FJ, Martínez D, González CM, Monteagudo I, Martínez-Barrio J, Garrido J, Naredo E.

Clin Exp Rheumatol. 2016 May-Jun;34(3):480-8.

PMID:
27050868
6.

Treatment with monoclonal antibodies and pregnancy in women with systemic inflammatory diseases: A special situation.

Valor L, Ovalles-Bonilla JG, Hernández-Flórez D, López-Longo FJ.

Reumatol Clin. 2016 Nov - Dec;12(6):359-360. doi: 10.1016/j.reuma.2016.01.006. English, Spanish. No abstract available.

7.

Agreement in assessment of infliximab and adalimumab levels in rheumatoid arthritis: interlaboratory and interassay comparison.

Valor L, Hernández-Flórez D, de la Torre I, Llinares F, Rosas J, Yagüe J, Garrido J, Naredo E.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):617-23.

PMID:
26316061
8.

Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients.

Valor L, Hernández-Flórez D, de la Torre I, Del Río T, Nieto JC, González C, López-Longo FJ, Monteagudo I, Llinares F, Rosas J, Garrido J, Naredo E, Carreño L.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):805-11.

PMID:
26314759
9.

Protein-kinase inhibitors: A new treatment pathway for autoimmune and inflammatory diseases?

Hernández-Flórez D, Valor L.

Reumatol Clin. 2016 Mar-Apr;12(2):91-9. doi: 10.1016/j.reuma.2015.06.004. English, Spanish.

10.

Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis.

Naredo E, Valor L, De la Torre I, Montoro M, Bello N, Martínez-Barrio J, Martínez-Estupiñán L, Nieto JC, Ovalles-Bonilla JG, Hernández-Flórez D, González CM, López-Longo FJ, Monteagudo I, Carreño L.

Rheumatology (Oxford). 2015 Aug;54(8):1408-14. doi: 10.1093/rheumatology/kev006.

11.

Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment.

Janta I, Martínez-Estupiñán L, Valor L, Montoro M, Baniandres Rodriguez O, Hernández Aragüés I, Bello N, Hernández-Flórez D, Hinojosa M, Martínez-Barrio J, Nieto-González JC, Ovalles-Bonilla JG, González CM, López-Longo FJ, Monteagudo I, Naredo E, Carreño L.

Clin Rheumatol. 2015 May;34(5):935-42. doi: 10.1007/s10067-015-2880-7.

PMID:
25636779
12.

Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis.

Hernández-Flórez D, Valor L, de la Torre I, Nieto JC, Martínez-Estupiñán L, González C, López-Longo FJ, Monteagudo I, Garrido J, Naredo E, Carreño L.

Rheumatol Int. 2015 Jun;35(6):1021-5. doi: 10.1007/s00296-014-3180-2.

PMID:
25410014
13.

Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.

Rosas J, Llinares-Tello F, de la Torre I, Santos-Ramírez C, Senabre-Gallego JM, Valor L, Barber-Vallés X, Hernández-Flórez D, Santos-Soler G, Salas-Heredia E, Carreño L; AIRE-MB Group..

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):942-8.

PMID:
25327159
14.

Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?

Naredo E, Hinojosa M, Valor L, Hernández-Flórez D, Mata-Martínez C, Serrano-Benavente B, Del Río T, Bello N, Montoro M, Nieto-González JC, González CM, López-Longo FJ, Monteagudo I, Carreño L.

Rheumatology (Oxford). 2014 Nov;53(11):2088-94. doi: 10.1093/rheumatology/keu248.

15.

Anti-TNF treatments in rheumatoid arthritis: economic impact of dosage modification.

de la Torre I, Valor L, Nieto JC, Hernández-Flórez D, Martinez L, Gonzalez CM, Monteagudo I, Longo JL, Montoro M, Carreño L.

Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):407-14. doi: 10.1586/erp.13.24. Erratum in: Expert Rev Pharmacoecon Outcomes Res. 2014 Aug;14(4):579. Hernandez, Diana [corrected to Hernández-Flórez, Diana].

PMID:
23763534
Items per page

Supplemental Content

Loading ...
Support Center